T. Koch

Spleen involvement in Hodgkin's lymphoma: assessment and risk profile

M. Sieber, A. Gossmann, A. Josting, 2003, Annals of Hematology.

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.

R. Greil, V. Diehl, J. Franklin, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.

M Sieber, A Engert, H. Eich, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.